This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Dec 8;365(23):2237; author reply 2237.

doi: 10.1056/NEJMc1107895.

Ranibizumab and bevacizumab for AMD

C M Gemmy Cheung, Tien Y Wong

PMID: 22150050
DOI: 10.1056/NEJMc1107895

Comment

Ranibizumab and bevacizumab for AMD

C M Gemmy Cheung et al. N Engl J Med. 2011.

. 2011 Dec 8;365(23):2237; author reply 2237.

doi: 10.1056/NEJMc1107895.

Authors

C M Gemmy Cheung, Tien Y Wong

PMID: 22150050
DOI: 10.1056/NEJMc1107895

No abstract available

PubMed Disclaimer

Comment on

Ranibizumab and bevacizumab for neovascular age-related macular degeneration.
CATT Research Group; Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ. CATT Research Group, et al. N Engl J Med. 2011 May 19;364(20):1897-908. doi: 10.1056/NEJMoa1102673. Epub 2011 Apr 28. N Engl J Med. 2011. PMID: 21526923 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information